Researchers and Reach
Our Researchers
The Snowdome Foundation supports exceptional Australian researchers and their dedication to advancing diagnostic tools and
treatments for blood cancer patients. Over the past 13 years, Snowdome has supported 67 research projects, which has enabled
over 98 research positions focused on different types of blood cancer. We are delighted to showcase the life-changing work of
these talented researchers and we remain committed to promoting collaboration between researchers and individuals who are
passionate about contributing to blood cancer research.
Since 2010, Snowdome has supported the following researchers:
| A/Prof Mary Ann Anderson | A/Prof Amit Khot | Prof Jeff Szer AM |
| A/Prof Piers Blombery | Tracy King | Dr Peter Tan |
| Dr Charles de Bock | Dr Jamie Kuzich | Dr Siok |
| Prof Richard Boyd | Emily Li | A/Prof Daniel Thomas |
| Dr Nicole Brooks | Prof Richard Lock | Dr Ella Thompson |
| Prof Chan Cheah | Dr Kylee MacLachlan | Dr Joshua Tobin |
| Dr Katherine Cummins | Prof Ravi Majeti | Prof Judith Trotman |
| Prof Mark Dawson | Dr Jacek Marzec | Dr Ashwin Unnikrishnan |
| A/Prof Michael | Dr Elizabeth Moore | Dr Kate Vandyke |
| Dr Pilar Dominguez | Prof Charles Mullighan | Dr Meaghan Wall |
| Dr Katie Fennell | Prof Stephen Nutt | Prof Andrew Wei |
| Dr Gareth Gregory | A/Prof Jane Oliaro | A/Prof David Westerman |
| Prof Sean Grimmond | Dr Michael Osborn | Dr Carrie van der Weyden |
| Dr Carolyn Grove | Prof John Pimanda | Dr Simon Willis |
| Dr Belinda Guo | Prof Miles Prince AM | Dr Colin Wood |
| A/Prof Eliza Hawkes | Dr Indu Raman | Dr Costas Yannakou |
| James Hicks | Prof David Ritchie | Dr Paul Yeh |
| Prof Ricky Johnstone | Prof Andrew Roberts AM | Dr Jessie Zhao |
| A/Prof Lev Kats | Prof Jake Shortt | |
| A/Prof Melita Kenealy | Prof Andrew Spencer |
International Reach
International collaboration and the exchange of knowledge play a crucial role in the advancement of translational research into innovative treatment options. Snowdome has collaborated with the Leukemia & Lymphoma Society (LLS) in the United States and the Leukaemia Foundation in Australia to drive forward ground-breaking blood cancer research via the LLS Translational Research Program. The program focuses on accelerating research that shows significant potential of translating into new clinical applications.
Now into its fifth year, the collaboration between our organisations has resulted in the funding of ten Australian research projects, worth a total of AUD $9 million.
